That's very interesting, I was in ATTB* when it ran to $2 back in 2014, before it became bloated, (post #22 all time actually https://investorshub.advfn.com/boards/read_msg.aspx?message_id=95700527) so Im familiar with nrthrn vine. VANC has real promise, largely buttressed by its relatively unscathed SS. It would be a good acquisition target for EMH especially if Canada commits to pharmacy distribution of THC derivatives. Time will tell my friend. GL